NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 08/24/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,484.18 mln
Float25.31 mln
Earnings Date12/15/2026
EPS
0.71
Stretched
P / E
136
Highly speculative
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-1.53
Likely manipulated
1-Year Forecast
120
Attractive
Relative Strength
30
/ 100
Underperforming
Business Description
BillionToOne is a California-based diagnostics company founded in 2016 that uses advanced DNA measurement technology to improve how diseases are detected and monitored. Its products include a prenatal blood test that screens for genetic conditions in unborn babies, as well as cancer tests that identify tumor mutations and track how well a patient is responding to treatment. These cancer tests work without requiring a tissue sample, making them less invasive while still delivering highly accurate results.
